FDA approves new Parkinson's treatment
Date: 11.5.2007
The U.S. Food and Drug Administration has announced approval of Neupro -- a skin patch designed to treat symptoms of early Parkinson's disease.
Neupro, the first transdermal patch approved for treatment of Parkinson's disease symptoms, involves the drug rotigotine, which was not previously approved for use in the United States.
Parkinson's disease, which belongs to a group of conditions called motor system disorders, results from the loss of dopamine-producing brain cells...
Whole article "ScienceDaily.com":[ http://www.sciencedaily.com/upi/index.php?feed=Science&article=UPI-1-20070510-07540900-bc-us-parkinsons.xml]
Related articles
Alzheimer's, Parkinson's, type 2 diabetes similar at molecular level - Alzheimer's disease, Parkinson's disease, type 2 diabetes, the human version of mad cow disease, and other degenerative diseases are more closely related at the molecular level than scientists realized, a team reports this week in an advanced online publication of the journal Nature (2.5.2007)
DNA nanoparticles hold promise in gene therapy for Parkinson's disease - University of Kentucky researcher David Yurek was recently awarded $66,000 by The Michael J (3.3.2007)
Parkinson's Disease - Parkinson's Disease Parkinson´s disease is the second most common neurodegeneration after Alzheimer´s disease ()
